Get ready for CAR NK cell manufacturing

Are you ready for your next step in cell and gene therapy? Are you ready for CAR NK cells? The CliniMACS Prodigy® NK Cell Transduction Process automates key steps in the manufacturing workflow, including cell selection, activation, viral transduction, and expansion. Profit from a closed and standardized process, consistent results and reduced operator hand-on time.

Learn more about the CliniMACS Prodigy Platform: https://www.miltenyibiotec.com/produc...

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.